Humana Inc.
HUM
$187.28
-$3.26-1.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.05% | 9.59% | 8.92% | 7.80% | 10.25% |
| Total Other Revenue | 17.20% | 48.52% | 28.39% | 25.68% | 14.01% |
| Total Revenue | 11.30% | 11.06% | 9.64% | 8.45% | 10.40% |
| Cost of Revenue | 13.16% | 11.43% | 10.09% | 5.62% | 11.41% |
| Gross Profit | -0.99% | 8.91% | 7.15% | 24.29% | 4.13% |
| SG&A Expenses | 9.80% | 16.26% | 13.18% | 11.38% | 13.29% |
| Depreciation & Amortization | -21.15% | -17.62% | -16.04% | -12.44% | 3.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.48% | 11.77% | 10.23% | 6.10% | 11.59% |
| Operating Income | -173.71% | -14.81% | -4.14% | 61.11% | -331.52% |
| Income Before Tax | -14.02% | -82.99% | -19.87% | 66.46% | -46.18% |
| Income Tax Expenses | -15.28% | -155.48% | -19.73% | 61.75% | -188.00% |
| Earnings from Continuing Operations | -13.62% | -59.58% | -19.91% | 68.06% | -26.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -- | 100.00% | 0.00% | -900.00% |
| Net Income | -14.86% | -59.38% | -19.73% | 67.88% | -28.10% |
| EBIT | -173.71% | -14.81% | -4.14% | 61.11% | -331.52% |
| EBITDA | -1,540.74% | -15.11% | -5.65% | 49.50% | -91.82% |
| EPS Basic | -14.97% | -59.33% | -19.80% | 68.31% | -30.23% |
| Normalized Basic EPS | -41.67% | -36.22% | -19.06% | 64.31% | -236.78% |
| EPS Diluted | -14.77% | -59.30% | -19.75% | 68.58% | -30.47% |
| Normalized Diluted EPS | -41.67% | -36.28% | -19.05% | 64.46% | -236.78% |
| Average Basic Shares Outstanding | -0.10% | -0.11% | 0.08% | -0.26% | -1.64% |
| Average Diluted Shares Outstanding | -0.10% | -0.02% | 0.07% | -0.35% | -1.64% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.12% | 1.46% | 0.23% | -0.41% | 0.24% |